Skip to content

TNXP

Tonix Pharmaceuticals Holding Corp.

NASDAQ · USHealthcareBiotechnology
$10.98-11.67%

Price as of Jul 20, 2026

TNXP capital

Tonix Pharmaceuticals Holding Corp. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.01x
Net debt / equity
-0.81x
Debt / assets
0.01x
Debt / EBITDA
-0.01x
Net debt / EBITDA
1.27x

Liquidity & coverage

Current ratio
6.99x
Quick ratio
6.86x
Cash ratio
6.26x
Interest coverage
EBITDA / interest
Working capital
$177.5M

Cash & dividend

FCF / debt
-102.83x
Cash flow / debt
-97.35x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.